Trendy Stocks
ChemoCentryx Inc. (CCXI) Stock Surges Following Approval of TAVNEOS by U.S. FDA
ChemoCentryx Inc. (CCXI) stock prices were up by 95.97% as of the market closing on October 8th, 2021. This brought the price per share up
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.